Yonsei Med J.  2017 Jan;58(1):195-205. 10.3349/ymj.2017.58.1.195.

Efficacy of Oxidized Regenerated Cellulose, SurgiGuard®, in Porcine Surgery

• Kim SH
• Kim SH
• Yoon HS
• Kim HK
• Kim KS

• KMID: 2374207
• DOI: http://doi.org/10.3349/ymj.2017.58.1.195

Abstract

PURPOSE
Adequate hemostasis is important for postoperative outcomes of abdominal surgery. This study evaluated the hemostatic effects and accompanying histopathological changes of a novel oxidized regenerated cellulose, SurgiGuard®, during abdominal surgery.
MATERIALS AND METHODS
Ten pigs underwent wedge resection of the spleen (1×1 cm) and liver (1.5×1.5 cm). The resected surface was covered with Surgicel® fabric or fibril type (Group A) or SurgiGuard® fabric or fibril type (Group B). Surgicel® and SurgiGuard® were randomized for attachment to the resected surface by fabric type (n=5) or fibril type (n=5). Blood loss was measured 5, 7, and 9 min after resection. Pigs were necropsied 6 weeks postoperatively to evaluate gross and histopathological changes.
RESULTS
There was no significant difference in total blood loss between groups [spleen fabric: Group A vs. Group B, 4.38 g (2.74-6.43) vs. 3.41 g (2.46-4.65), p=0.436; spleen fibril: Group A vs. Group B, 3.44 g (2.82-6.07) vs. 3.60 g (2.03-6.09), p=0.971; liver fabric: Group A vs. Group B, 4.51 g (2.67-10.61) vs. 6.93 g (3.09-9.95), p=0.796; liver fibril: Group A vs. Group B, 3.32 g (2.50-8.78) vs. 3.70 g (2.32-5.84), p=0.971]. Histopathological analysis revealed no significant difference in toxicities related to Surgicel® or SurgiGuard® [inflammation, fibrosis, foreign bodies, and hemorrhage (spleen: p=0.333, 0.127, 0.751, and 1.000; liver: p=0.155, 0.751, 1.000, and 1.000, respectively)].
CONCLUSION
SurgiGuard® is as effective and non-toxic as Surgicel® in achieving hemostasis after porcine abdominal surgery.

Keyword

Animal model; blood loss; hemostatics; histopathology; oxidized regenerated cellulose

MeSH Terms

Animals
*Blood Loss, Surgical/statistics & numerical data
Cellulose, Oxidized/*therapeutic use
Hemostasis, Surgical/*methods
Hemostatics/*therapeutic use
Liver/*surgery
Random Allocation
Spleen/*surgery
Swine
Cellulose, Oxidized
Hemostatics
Surgicel

Figure

• 

  Fig. 1 Weight of the resected organs and blood loss in accordance with time and type.

• 

  Fig. 2 Microscopic findings of resected spleen surface (Fabric type, hematoxylin and eosin stain, ×100).

• 

  Fig. 3 Microscopic findings of resected spleen surface (Fibril type, hematoxylin and eosin stain, ×100).

• 

  Fig. 4 Microscopic findings of resected liver surface (Fabric type, hematoxylin and eosin stain, ×100).

• 

  Fig. 5 Microscopic findings of resected liver surface (Fibril type, hematoxylin and eosin stain, ×100).

Reference

1. Dagi TF. The management of postoperative bleeding. Surg Clin North Am. 2005; 85:1191–1213.

2. Zwischenberger JB, Brunston RL Jr, Swann JR, Conti VR. Comparison of two topical collagen-based hemostatic sponges during cardiothoracic procedures. J Invest Surg. 1999; 12:101–106.

3. Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg. 2010; 251:217–228.

4. Tan SR, Tope WD. Effectiveness of microporous polysaccharide hemospheres for achieving hemostasis in mohs micrographic surgery. Dermatol Surg. 2004; 30:908–914.

5. Tanizawa Y, Bando E, Kawamura T, Tokunaga M, Ono H, Terashima M. Early postoperative anastomotic hemorrhage after gastrectomy for gastric cancer. Gastric Cancer. 2010; 13:50–57.

6. Martínez-Serrano MA, Parés D, Pera M, Pascual M, Courtier R, Egea MJ, et al. Management of lower gastrointestinal bleeding after colorectal resection and stapled anastomosis. Tech Coloproctol. 2009; 13:49–53.

7. Rahbari NN, Garden OJ, Padbury R, Maddern G, Koch M, Hugh TJ, et al. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford). 2011; 13:528–535.

8. Jones S, May AK. Postoperative gastrointestinal hemorrhage. Surg Clin North Am. 2012; 92:235–242.

9. Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth. 2013; 110:690–701.

10. Nash GF, Chopada A, Patel H, Kakkar AK. Stored blood products stimulate cancer growth. Br J Surg. 2002; 89:19.

11. Kanko M, Liman T, Topcu S. A low-cost and simple method to stop intraoperative leakage-type bleeding: use of the vancomycin-oxidized regenerated cellulose (ORC) sandwich. J Invest Surg. 2006; 19:323–327.

12. Frantz VK. Absorbable cotton, paper and gauze: (oxidized cellulose). Ann Surg. 1943; 118:116–126.

13. Simo KA, Hanna EM, Imagawa DK, Iannitti DA. Hemostatic agents in hepatobiliary and pancreas surgery: a review of the literature and critical evaluation of a novel carrier-bound fibrin sealant (tachoSil). ISRN Surg. 2012; 2012:729086.

14. Sabel M, Stummer W. The use of local agents: surgicel and surgifoam. Eur Spine J. 2004; 13:Suppl 1. S97–S101.

15. Phillips JD, Kim CS, Fonkalsrud EW, Zeng H, Dindar H. Effects of chronic corticosteroids and vitamin A on the healing of intestinal anastomoses. Am J Surg. 1992; 163:71–77.

16. Chvapil M, Owen JA, DeYoung DW. A standardized animal model for evaluation of hemostatic effectiveness of various materials. J Trauma. 1983; 23:1042–1047.

17. Koea JB, Batiller J, Patel B, Shen J, Hammond J, Hart J, et al. A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery. HPB (Oxford). 2013; 15:61–70.

18. Velázquez-Aviña J, Mönkemüller K, Sakai P, Sulbaran M, Chávez-Vargas C, Montalvo Javé E, et al. Hemostatic effect of oxidized regenerated cellulose in an experimental gastric mucosal resection model. Endoscopy. 2014; 46:878–882.

19. Hutchinson RW, Broughton D, Barbolt TA, Poandl T, Muench T, Rockar R, et al. Hemostatic effectiveness of Fibrin pad after partial nephrectomy in swine. J Surg Res. 2011; 167:e291–e298.

20. Matonick JP, Hammond J. Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model. J Invest Surg. 2014; 27:360–365.

21. Muench TR, Kong W, Harmon AM. The performance of a hemostatic agent based on oxidized regenerated cellulose--polyglactin 910 composite in a liver defect model in immunocompetent and athymic rats. Biomaterials. 2010; 31:3649–3656.

22. Giuliani M, Fubelli R, Patrolecco F, Rella R, Borelli C, Buccheri C, et al. Mammographic and ultrasonographic findings of oxidized regenerated cellulose in breast cancer surgery: a 5-year experience. Clin Breast Cancer. 2015; 15:e249–e256.

23. Tomizawa Y. Clinical benefits and risk analysis of topical hemostats: a review. J Artif Organs. 2005; 8:137–142.

24. Dineen P. The effect of oxidized regenerated cellulose on experimental intravascular infection. Surgery. 1977; 82:576–579.

25. Gottrup F, Cullen BM, Karlsmark T, Bischoff-Mikkelsen M, Nisbet L, Gibson MC. Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment. Wound Repair Regen. 2013; 21:216–225.

26. Alfieri S, Di Miceli D, Menghi R, Quero G, Cina C, Pericoli Ridolfini M, et al. Role of oxidized regenerated cellulose in preventing infections at the surgical site: prospective, randomized study in 98 patients affected by a dirty wound. Minerva Chir. 2011; 66:55–62.

27. Bullen AW, Losowsky MS. Consequences of impaired splenic function. Clin Sci (Lond). 1979; 57:129–137.

28. Khan PN, Nair RJ, Olivares J, Tingle LE, Li Z. Postsplenectomy reactive thrombocytosis. Proc (Bayl Univ Med Cent). 2009; 22:9–12.

29. Katti DS, Lakshmi S, Langer R, Laurencin CT. Toxicity, biodegradation and elimination of polyanhydrides. Adv Drug Deliv Rev. 2002; 54:933–961.

30. Behbehani S, Tulandi T. Oxidized regenerated cellulose imitating pelvic abscess. Obstet Gynecol. 2013; 121:2 Pt 2 Suppl 1. 447–449.

31. Wang H, Chen P. Surgicel® (oxidized regenerated cellulose) granuloma mimicking local recurrent gastrointestinal stromal tumor: a case report. Oncol Lett. 2013; 5:1497–1500.

32. Postoperative adhesion. evaluation at early second-look procedures. Operative Laparoscopy Study Group. Fertil Steril. 1991; 55:700–704.

33. Raftery AT. Absorbable haemostatic materials and intraperitoneal adhesion formation. Br J Surg. 1980; 67:57–58.

34. Ates U, Ata B, Ortakuz S, Seyhan A, Urman B. Prevention of adhesion formation following ovarian surgery in a standardized animal model: comparative study of Interceed and double layer Surgicell. J Obstet Gynaecol Res. 2008; 34:12–17.

35. Ahmad G, O'Flynn H, Hindocha A, Watson A. Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2015; (4):CD000475.